Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.19M Sell
663,207
-68
-0% -$632 ﹤0.01% 1504
2026
Q1
$6.64M Buy
663,275
+551,449
+493% +$5.74M ﹤0.01% 1422
2025
Q4
$1.13M Buy
+111,826
New +$1.06M ﹤0.01% 2099

Other funds holding HLN

UBS AM's HLN Position: Q2 2026 in Review

UBS AM reduced its Haleon (HLN) stake by 0.01% in Q2 2026, selling an estimated $632 and leaving 663,207 shares worth $6.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1504.

UBS AM first reported a position in HLN in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.64M in Q1 2026. 641 funds tracked by Wall St. Rank hold HLN as of Q2 2026.

  • UBS AM held 663,207 shares of Haleon worth $6.19M as of Q2 2026.
  • UBS AM sold 68 Haleon shares in Q2 2026, an estimated $632.
  • Haleon made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1504 holding.
  • UBS AM first reported a position in Haleon in Q4 2025 and has held it in 3 quarters since.
  • UBS AM's Haleon position peaked at $6.64M in Q1 2026.
  • 641 funds tracked by Wall St. Rank held Haleon as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.